In two to three years, it will develop into a gene diagnosis kit manufacturer with international leading technology level, the largest production scale in China, strong R&D capability and a certain international reputation, and build the largest R&D and production base of genetic testing products in China.
2. Development strategy
Guided by the market, driven by scientific and technological innovation, centered on maximizing the interests of shareholders, we adhere to the principle of humanized management, make full use of the advantages of talents, products and technology, make the company develop stably, continuously and rapidly, implement the big service strategy, maintain and expand its leading position in the same industry at home and abroad, and continue to lead the development direction of China's genetic diagnosis industry.
3. Development priorities
Highlight the research and application of fluorescence quantitative PCR detection technology to deepen the main business; On the basis of strengthening existing products and businesses, we will continue to develop new technologies and products, so that products will develop in the direction of diversification, matching and serialization. In order to implement the company's development strategy, by 20 10, the annual sales scale of the company's kit products will reach 20 million sets, the company's main business income (including kit sales, technical service income and medical diagnosis income) and profitability will increase substantially, and the company's overall competitiveness will be further enhanced on the basis of existing advantages.